GRETCHEN FOWELL: Open Payments
NPI 1649209867 · GREAT FALLS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 28 payments from 8 companies in 2025. Trend: 2023 $310 · 2024 $492 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $317 |
| Astellas Pharma US Inc | 2 | $65 |
| Sage Therapeutics, LLC | 2 | $47 |
| Daiichi Sankyo Inc. | 2 | $35 |
| Organon LLC | 1 | $18 |
| CooperSurgical, Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Octapharma USA, Inc. | 1 | $16 |
Products named: UBRELVY, QULIPTA, Veozah, ZURZUVAE, INJECTAFER, NEXPLANON, Paragard T 380A, Qelbree.
Industry payments across MT — which companies pay providers there.
